Mulligan Mobilization With Movement in Patients With Unilateral Anterior Sacral Nutation.

February 23, 2026 updated by: Riphah International University

Effect of Mulligan Mobilization With Movement on Pain, Range of Motion and Disability in Patients With Unilateral Anterior Sacral Nutation.

Somatic Dysfunction of the SIJ is defined as hypo or hyper-mobility of the joint in addition to a malalignment or change of positioning of the sacrum and ilium bones (e.g. Forward sacral torsion, backward sacral torsion, bilateral anterior or posterior sacral nutation, Unilateral anterior and posterior sacral nutation). The classic physical signs for a dysfunction of the sacroiliac joint in which a unilateral anterior nutation of the sacrum or ilium has occurred in the sagittal plane about a transverse axis are: Sacral sulcus seen deeper, PSIS seen Caudad, Inferior lateral angle (ILA) seen Posterior, Pubic tubercle seen as Cephalad, ASIS as Cephalad, Sacroiliac joint seen upper pole and tender, Sacrospinous and Sacrotuberous ligament are under tension and gait abnormality seen due to leg length discrepancy.

Study Overview

Detailed Description

A randomized control trial will be conducted to determine the effects of mulligan mobilization with movement in order to improve pain, lumbar range of motion and functional disability in patients with unilateral anterior sacral nutation. A sample size of 41 subjects will be taken, Data will be collected from Gosh-e-Shifa Medical Rehabilitation Centre and Al-Raheem Physiotherapy Centre of Lahore. Outcome measures will be taken using Numeric pain rating scale (NPRS) for pain, Lumbar flexion by Goniometer and Modified Oswestry Disability Index (MODI) for functional Disability. A written consent form will be taken from participants meeting inclusion criteria and will be randomly allocated in two groups (Group A and Group B) of equal members. Group A (Experimental group) will receive mulligan mobilization with movement along with standardized physiotherapy intervention. While Group B will receive only standardized physiotherapy intervention. Over the course of 6 weeks, all participants in the control group and the experimental group will attend a total of 18 intervention sessions (three times per week). All participants in both groups will be evaluated before and after the treatment programs.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lahore, Pakistan, 56700
        • Gosh-e-Shifa Hospital and Al Raheem Physiotherapy Centre, Lahore.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Numeric pain rating score from 3 to 7 (Pain around or close to the sacral sulcus)
  • Patients with a minimum of 3 positive results from among the 5 provocation tests that show sacroiliac joint dysfunction.
  • Fuctional Leg length discrepancy.
  • Using no other nonsteroidal anti-inflammatory drugs during the therapy.

Exclusion Criteria:

  • Prolapsed intervertebral disc (PIVD)
  • Lumbar canal stenosis
  • Tumors or any traumatic condition to pelvis and lower limb.
  • Lumbar surgery within a year prior to the study or reported vertebral fracture,
  • Pregnancy
  • Ankylosing spondylitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan Mobilization with conservative treatment.
Participants receive Mulligan mobilization and baseline physical therapy.
Participants receive Mulligan mobilization (10 Repetitions of 3 sets with 5 minutes rest period between each set) and baseline physical therapy intervention.Joint mobilization will be accomplished by using the posterior innominate (on affected side) and anterior innominate (on unaffected side) techniques (Mobilization with Movement).
Active Comparator: Only conservative treatment.
Participants receive baseline physical therapy intervention.
  • Hot pack for 10 minutes (32). (Electric Medicare Heating pad)
  • TENS with frequency of 120Hz at low intensity below the local painful sensory threshold with pulse of width 50-200 μs for 10 minutes (33).
  • SIJ Stretching Exercises (hamstring stretches, hip adductor stretch, piriformis stretch, quadriceps stretch, one knee to chest stretch, both knees to chest stretch, lower trunk rotation, and pelvic rotation stretch) (1).
  • Core Strengthening Exercises (Isometric hip abduction/adduction strengthening)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mitchell Model for Unilateral Anterior Sacral Nutation
Time Frame: 8 weeks
Osteopathic authors have adopted several models to assess and diagnose the presence of sacroiliac dysfunction. The Mitchell model recommends static bony palpatory findings combined with motion tests as a basis for determining the presence and nature of SIJD (25). Physiotherapists employed diagnostic techniques congruent with Mitchell's model, but they also frequently added additional motion tests, measured tenderness, and used pain provocation techniques
8 weeks
Numerical Pain Rating Scale (NPRS)
Time Frame: 8 weeks

Patient level of pain will be assessed using this scale. This scale ranges from 0 to 10.

0 indicates "no pain" and 10 indicates "worst pain". Clinicians can be confident that a 2point change on the NPRS represents clinically meaningful change that exceeds the bounds of measurement error. NPRS shave shown high test-retest reliability(r=0.96)

8 weeks
Modified Oswestry Disability Index (MODI)
Time Frame: 8 weeks
MODQ is a valid and reliable tool for the assessment of the disability following low back pain. The thorough questionnaire demonstrated good reliability, good internal consistency, and confirmed convergent validity. The physical component domain of the SF-36 (r=-0.55, p<0.001) showing that MODI is measuring what it is supposed to measure in terms of disability and physical function.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Goniometer
Time Frame: 8 weeks
It is recommended in clinical practice that the instruments for measuring spinal ROM should be valid and reliable, should have low cost and are easy to use. Study recommend the use of instruments with lower costs and easier handling, as the goniometer
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Faiza Taufiq, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2025

Primary Completion (Actual)

January 15, 2026

Study Completion (Actual)

January 15, 2026

Study Registration Dates

First Submitted

February 23, 2026

First Submitted That Met QC Criteria

February 23, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 23, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Mulligan mobilization with movement.

Subscribe